These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19528473)

  • 1. Proton transport inhibitors as potentially selective anticancer drugs.
    Harguindey S; Arranz JL; Wahl ML; Orive G; Reshkin SJ
    Anticancer Res; 2009 Jun; 29(6):2127-36. PubMed ID: 19528473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature.
    Harguindey S; Orive G; Luis Pedraz J; Paradiso A; Reshkin SJ
    Biochim Biophys Acta; 2005 Sep; 1756(1):1-24. PubMed ID: 16099110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs--an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research.
    Harguindey S; Arranz JL; Polo Orozco JD; Rauch C; Fais S; Cardone RA; Reshkin SJ
    J Transl Med; 2013 Nov; 11():282. PubMed ID: 24195657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells.
    Chen M; Zou X; Luo H; Cao J; Zhang X; Zhang B; Liu W
    Cell Biol Int; 2009 Sep; 33(9):1008-19. PubMed ID: 19501661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy.
    Spugnini EP; Citro G; Fais S
    J Exp Clin Cancer Res; 2010 May; 29(1):44. PubMed ID: 20459683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism.
    Fais S
    J Intern Med; 2010 May; 267(5):515-25. PubMed ID: 20433578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of tonoplast proton pumps and Na+/H+ exchange in potato cell cultures is modulated by salt.
    Queirós F; Fontes N; Silva P; Almeida D; Maeshima M; Gerós H; Fidalgo F
    J Exp Bot; 2009; 60(4):1363-74. PubMed ID: 19213810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor acidity, chemoresistance and proton pump inhibitors.
    De Milito A; Fais S
    Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Na+-H+ exchanger, pH regulation and cancer.
    Reshkin SJ; Cardone RA; Harguindey S
    Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):85-99. PubMed ID: 22738122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vacuolar H(+)-ATPase: functional mechanisms and potential as a target for cancer chemotherapy.
    Torigoe T; Izumi H; Ise T; Murakami T; Uramoto H; Ishiguchi H; Yoshida Y; Tanabe M; Nomoto M; Kohno K
    Anticancer Drugs; 2002 Mar; 13(3):237-43. PubMed ID: 11984067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting vacuolar H+-ATPases as a new strategy against cancer.
    Fais S; De Milito A; You H; Qin W
    Cancer Res; 2007 Nov; 67(22):10627-30. PubMed ID: 18006801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system.
    Peluso G; Nicolai R; Reda E; Benatti P; Barbarisi A; Calvani M
    J Cell Physiol; 2000 Mar; 182(3):339-50. PubMed ID: 10653600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer.
    Gerweck LE; Seetharaman K
    Cancer Res; 1996 Mar; 56(6):1194-8. PubMed ID: 8640796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer.
    Hernandez A; Serrano-Bueno G; Perez-Castineira JR; Serrano A
    Curr Pharm Des; 2012; 18(10):1383-94. PubMed ID: 22360554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton channels and exchangers in cancer.
    Spugnini EP; Sonveaux P; Stock C; Perez-Sayans M; De Milito A; Avnet S; Garcìa AG; Harguindey S; Fais S
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2715-26. PubMed ID: 25449995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoskeleton structure and dynamic behaviour: quick excursus from basic molecular mechanisms to some implications in cancer chemotherapy.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2009; 13(1):13-21. PubMed ID: 19364082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-based targeted therapy for cancer tissue.
    Das M; Mohanty C; Sahoo SK
    Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy.
    Izumi H; Torigoe T; Ishiguchi H; Uramoto H; Yoshida Y; Tanabe M; Ise T; Murakami T; Yoshida T; Nomoto M; Kohno K
    Cancer Treat Rev; 2003 Dec; 29(6):541-9. PubMed ID: 14585264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of H+-vacuolar ATPase by the energy blocker 3-bromopyruvate, a new antitumour agent.
    Dell'Antone P
    Life Sci; 2006 Oct; 79(21):2049-55. PubMed ID: 16908033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-responsive nanoparticles for cancer drug delivery.
    Shen Y; Tang H; Radosz M; Van Kirk E; Murdoch WJ
    Methods Mol Biol; 2008; 437():183-216. PubMed ID: 18369970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.